A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment

Area of Science:

• Oncology
• Immunology
• Cancer Biology

Background:

• Tumors often contain hypoxic regions, creating harsh conditions for immune cells.
• Hypoxia drives tumor cells to adapt via aerobic glycolysis and promotes extracellular adenosine accumulation.
• Extracellular adenosine binds to immune cell receptors, suppressing pro-inflammatory responses and promoting immunosuppression.

Purpose of the Study:

• To investigate the role of the hypoxia-adenosine pathway in tumor immune evasion.
• To explore the potential of targeting this pathway for cancer immunotherapy.

Main Methods:

• Analysis of tumor microenvironment characteristics, including hypoxia and adenosine levels.
• Evaluation of immune cell responses within the tumor microenvironment.
• Preclinical studies involving inactivation of adenosine receptors, inhibition of adenosine-producing enzymes, and reversal of hypoxia.

Main Results:

• Hypoxia and extracellular adenosine contribute to a long-lasting immunosuppressive tumor environment.
• Tumor cells adapt to hypoxia through aerobic glycolysis.
• Preclinical models demonstrated tumor regression upon targeting the hypoxia-adenosine pathway.

Conclusions:

• The hypoxia-adenosine pathway is a critical tumor survival mechanism that suppresses anti-tumor immunity.
• Inhibitors of the hypoxia-adenosine pathway represent a promising therapeutic strategy for cancer immunotherapy.